Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

RATIONALE & OBJECTIVE: The approved therapeutic indication for immune checkpoint inhibitors (CPIs) are rapidly expanding including treatment in the adjuvant setting, the immune related toxicities associated with CPI can limit the efficacy of these agents. The literature on the nephrotoxicity of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Mamlouk, Omar, Selamet, Umut, Machado, Shana, Abdelrahim, Maen, Glass, William F., Tchakarov, Amanda, Gaber, Lillian, Lahoti, Amit, Workeneh, Biruh, Chen, Sheldon, Lin, Jamie, Abdel-Wahab, Noha, Tayar, Jean, Lu, Huifang, Suarez-Almazor, Maria, Tannir, Nizar, Yee, Cassian, Diab, Adi, Abudayyeh, Ala
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6322290/
https://ncbi.nlm.nih.gov/pubmed/30612580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0478-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados